TVRD — Tvardi Therapeutics Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Tvardi Therapeutics Inc (TVRD), worth $1.52M combined. Over the quarter 1 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Slate Path | $1.34M | 0.02% | NO CHANGE |
| Renaissance | $173.68K | 0.00% | -0.8% |
| Persistent | $8.08K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.